YAZICI, O. Et Al. 2021. Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8 , 1229-1235.

YAZICI, O., Dogan, M., Ozal, G., AKTAŞ, S. H., Demirkazik, A., UTKAN, G., ... ÇAY ŞENLER, F.(2021). Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, 1229-1235.

YAZICI, OZAN Et Al. "Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer," COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, 1229-1235, 2021

YAZICI, OZAN Et Al. "Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer." COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, pp.1229-1235, 2021

YAZICI, O. Et Al. (2021) . "Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer." COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, pp.1229-1235.

@article{article, author={OZAN YAZICI Et Al. }, title={Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer}, journal={COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING}, year=2021, pages={1229-1235} }